{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:22Z","timestamp":1790638642729,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CORESTEM Inc","award":["CS10BR05"],"award-info":[{"award-number":["CS10BR05"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stem Cells International"],"published-print":{"date-parts":[[2021,10,19]]},"abstract":"<jats:p>Background. This study is aimed at investigating the safety and tolerability of the intra-arterial administration of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with multiple system atrophy- (MSA-) cerebellar type (MSA-C). Methods. This was a single-center, open-label phase I clinical trial in patients with MSA-C. A three-stage dose escalation scheme (low-dose, <jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mn>3.0<\/a:mn>\n                        <a:mo>\u00d7<\/a:mo>\n                        <a:msup>\n                           <a:mrow>\n                              <a:mn>10<\/a:mn>\n                           <\/a:mrow>\n                           <a:mrow>\n                              <a:mn>5<\/a:mn>\n                           <\/a:mrow>\n                        <\/a:msup>\n                     <\/a:math>\n                  <\/jats:inline-formula> cells\/kg; medium-dose, <jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mn>6.0<\/c:mn>\n                        <c:mo>\u00d7<\/c:mo>\n                        <c:msup>\n                           <c:mrow>\n                              <c:mn>10<\/c:mn>\n                           <\/c:mrow>\n                           <c:mrow>\n                              <c:mn>5<\/c:mn>\n                           <\/c:mrow>\n                        <\/c:msup>\n                     <\/c:math>\n                  <\/jats:inline-formula> cells\/kg; high-dose, <jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mn>9.0<\/e:mn>\n                        <e:mo>\u00d7<\/e:mo>\n                        <e:msup>\n                           <e:mrow>\n                              <e:mn>10<\/e:mn>\n                           <\/e:mrow>\n                           <e:mrow>\n                              <e:mn>5<\/e:mn>\n                           <\/e:mrow>\n                        <\/e:msup>\n                     <\/e:math>\n                  <\/jats:inline-formula> cells\/kg) was applied to determine the maximum tolerated dose of intra-arterial administration of BM-MSCs based on the no-observed-adverse-effect level derived from the toxicity study. The occurrence of adverse events was evaluated 1 day before and 1, 14, and 28 days after BM-MSC therapy. Additionally, we assessed changes in the Unified MSA Rating Scale (UMSARS) score 3 months after BM-MSC treatment. Results. One serious adverse drug reaction (ADR) of leptomeningeal enhancement following the intra-arterial BM-MSC administration occurred in one patient in the low-dose group. The safety review of the Internal Monitoring Committee interpreted this as radiological evidence of the blood-brain barrier permeability for MSCs. No other ADRs were observed in the medium- or high-dose groups. In particular, no ischemic lesions on diffusion-weighted images were observed in any of the study participants. Additionally, the medium- and high-dose groups tended to show a slower increase in UMSARS scores than the low-dose group during the 3-month follow-up. Conclusion. The present study confirmed that a single intra-arterial administration of autologous BM-MSCs is a safe and promising neuroprotective strategy in patients with MSA-C.<\/jats:p>","DOI":"10.1155\/2021\/9886877","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T04:00:46Z","timestamp":1634702446000},"page":"1-10","source":"Crossref","is-referenced-by-count":13,"title":["Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-3199","authenticated-orcid":true,"given":"Seok Jong","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"},{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin 16995, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-0498","authenticated-orcid":true,"given":"Tae Yong","family":"Lee","sequence":"additional","affiliation":[{"name":"Bioengineering Institute, CORESTEM Inc., Seoul 04763, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-9752","authenticated-orcid":true,"given":"Yang Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7215-375X","authenticated-orcid":true,"given":"KyoungWon","family":"Baik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-2975","authenticated-orcid":true,"given":"Jin Ho","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"},{"name":"Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan 47392, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7846-6271","authenticated-orcid":true,"given":"Han Soo","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-2265","authenticated-orcid":true,"given":"Chang Jae","family":"Shim","sequence":"additional","affiliation":[{"name":"Bioengineering Institute, CORESTEM Inc., Seoul 04763, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-0640","authenticated-orcid":true,"given":"Hyojin","family":"Eom","sequence":"additional","affiliation":[{"name":"Bioengineering Institute, CORESTEM Inc., Seoul 04763, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-0381","authenticated-orcid":true,"given":"Ji-Yeon","family":"Hong","sequence":"additional","affiliation":[{"name":"Bioengineering Institute, CORESTEM Inc., Seoul 04763, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7035-087X","authenticated-orcid":true,"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6533-2610","authenticated-orcid":true,"given":"Young H.","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-8462","authenticated-orcid":true,"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"},{"name":"Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00407-8"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0104-4"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70288-1"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006926"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21501"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn291"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22732"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6655-7"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70301-6"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70288-1"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30141-3"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100386"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23612"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000007720"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20886"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.075"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2016-0111"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2650"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101908"},{"key":"20","article-title":"Phase I trial of intra-arterial administration of autologous bone marrow-derived mesenchymal stem cells in patients with multiple system atrophy","author":"S. J. Chung"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"issue":"2","key":"22","first-page":"300","article-title":"A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients","volume":"15","author":"Y. W. Kang","year":"1997","journal-title":"Journal of the Korean Neurological Association"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27080"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2009.5.1.1"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019808"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121425.42966.F1"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20731"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.01.028"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1605-6"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23655"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.502047"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.12.017"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2006.05.015"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.05.011"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.07.021"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2008.03.010"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027877"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1177\/0963689717715824"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.3727\/096368914X678337"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20678"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21734"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000310413.04462.6a"},{"key":"44","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"H. Watanabe","year":"2002","journal-title":"Brain"}],"container-title":["Stem Cells International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/sci\/2021\/9886877.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/sci\/2021\/9886877.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/sci\/2021\/9886877.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T04:00:53Z","timestamp":1634702453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/sci\/2021\/9886877\/"}},"subtitle":[],"editor":[{"given":"Stefan","family":"Arnhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":44,"alternative-id":["9886877","9886877"],"URL":"https:\/\/doi.org\/10.1155\/2021\/9886877","relation":{},"ISSN":["1687-9678","1687-966X"],"issn-type":[{"value":"1687-9678","type":"electronic"},{"value":"1687-966X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}